Prof. zhu F and colleagues also demonstrated that MET, as an upstream molecule of TOPK, directly phosphorylates TOPK at the Y74, resulting in reduced apoptosis in gefitinib-resistant NSCLC cells, which in turn is involved in the development of drug resistance [31]. This evidence concerns the gene MET and non-small cell lung carcinoma.